Replies to post #751556 on NorthWest Biotherapeutics Inc (NWBO)

[KRISGO]

In 2024, the company diluted a total of 152,343,464 shares at an average price of around 40 cents, generating approximately 61 million in revenue. Do we know how this money has been utilized? Is there any accountability, or are we expected to just blindly trust that the company is spending it on something beneficial for all of us, without questioning how or where it's being spent?